FDA.reportPublic FDA data

14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler

RxCUI
1547666
RxNorm name
14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler
Display name
14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler
Full name
14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
50f193ee-1691-486d-9370-a664df63695c14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder InhalerSCD17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
50f193ee-1691-486d-9370-a664df63695cfluticasone furoate 200 MCG/INHAL Dry Powder Inhaler, 14 BlistersPSN17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
50f193ee-1691-486d-9370-a664df63695cfluticasone furoate 200 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUATSY17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018